Resistance against subcutaneous insulin successfully managed with aprotinin.
D007611:Aprotinin / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism; D007333:Insulin Resistance; D008875:Middle Aged
D007328:Insulin; D007611:Aprotinin